Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · DHAMPUR BIO ORGANICS LTD · 29 October 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
DHAMPUR BIO ORGANICS LTD
NSE: DBOL · BSE: 543593

DHAMPUR BIO ORGANICS LTD

StateQ1 FY27 filed
Last close · 28 Oct 2026₹126.83
Market cap₹0.8k cr
TTM P/E · P/B · EV/EBITDA9.9 · 0.82 · 11.1

Produces sugar, ethanol, and country liquor from sugarcane in Uttar Pradesh. Its FY26 revenue of Rs 3,133.41 cr came from three segments: Sugar (Rs 1,843.22 cr, 54.5% of segment revenue), Country Liquor (Rs 1,136.41 cr, 33.6%), and Bio Fuels & Spirits (Rs 400.63 cr, 11.9%). Sugar is the largest profit contributor with EBIT of Rs 131.29 cr; Country Liquor is the fastest growing line, with volumes up 45.16% YoY to 11.24 lakh cases in Q1 FY26 and management targeting 5-6% share of the Uttar Pradesh market (currently around 4%, ranked #7). Operations include sugar mills that crushed 35.3 lakh tons of cane in SS24-25 at a net recovery of 9.55%, a 300 KLPD distillery at Asmoli expanded by 100 KLPD via a dual-feed (molasses + grain) line commissioned in June 2025, and a grain ethanol plant brought online with FCI rice allocation. Q1 FY26 ethanol volumes sold were 19.33 mn liters, including 15.51 mn liters from B-heavy syrup, sold at Rs 59.64/liter. Costs are dominated by materials at 47.1% of revenue and other operating expenses at 41.2%. In June 2026, the company sold its Meerganj sugar and co-generation unit for Rs 305 cr on a slump-sale basis, booked a Rs 63.89 cr gain, and completed a 74% stake acquisition in DBION Private Limited (formerly Sonitron Chemicals) as a JV with Orgonew. AR · MarketPing reader · 2026-08-02

Revenue streams, as the annual report describes them. Sugar (55%), Country Liquor (34%), Bio Fuels & Spirits (12%). Cyclical, agro-processing business integrated across sugar, ethanol and potable liquor

What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.

Exhibit 1: Financial summary, FY23–FY26 (all audited; no estimate years)

₹ crore · consolidatedFY23FY24FY25FY26
Revenue2,6542,3942,6933,133
EBITDA (ex other income)205136133131
margin %7.75.74.94.2
Owners' profit111461725
EPS, as reported (₹)16.747.002.213.81
ROE % · ROCE %11.2 · 14.44.6 · 8.81.5 · 6.32.5 · 7.9
Debt / equity (x)0.811.031.141.03
Cash from operations355(101)130220
Capex(210)(171)(146)(44)
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · DHAMPUR BIO ORGANICS LTD · 29 October 2026Page 2 of 3

Exhibit 2: Quarterly performance, last 8 quarters

₹ croreQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue634719703784825751774919
Profit before tax(35)(10)61(33)(23)2672(18)
Net profit(23)(7)45(22)(16)174637
EPS (₹)(3.52)(1.03)6.75(3.31)(2.41)2.567.015.59
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.

Exhibit 3: Segment revenue, FY26

SegmentRevenue, ₹ croreShare %
Sugar1,84354.5
Bio Fuels & Spirits40111.9
Country Liquor1,13633.6
Total, before eliminations3,380100.0
Source: the filed segment block, four quarters summed.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · DHAMPUR BIO ORGANICS LTD · 29 October 2026Page 3 of 3

Exhibit 4: Filings of the last 90 days, with the measured price reaction

Date · filingCategoryImportanceNext day %5-day %
27 Oct 2026 · Cost auditor's death date corrected to October 18, 2026management changeslow——
22 Oct 2026 · Cost Auditor Surendra Rai Kapur died; replacement process initiatedmanagement changesmedium——
19 Oct 2026 · Dhampur Bio signs tech licence deal with Planetary SA for Mycoproteinstrategic transactionsmedium——
12 Oct 2026 · Compliance certificate: no physical shares held as of Sept 30, 2026complianceminimal——
1 Oct 2026 · Two senior executives promoted to Vice President roles at Dhampur Bio Organicsmanagement changeslow——
30 Sept 2026 · Promoter Sonitron Ltd buys shares in open market across 3 daysownership changeshigh——
30 Sept 2026 · Sonitron Ltd (promoter) buys 85,000 shares of Dhampur Bio Organics in 3 daysownership changesmedium——
26 Sept 2026 · Trading Window Closed from Oct 1 for Q2 FY26 Resultscomplianceminimal——
25 Sept 2026 · Promoter Sonitron buys 10000 shares of Dhampur Bio Organicsownership changeshigh——
25 Sept 2026 · Promoter group Sonitron Ltd buys 10,000 shares of Dhampur Bio Organicsownership changeshigh——
Source: exchange announcements; each reaction is measured from the close before the filing. Next day = the close one session after the reaction day (the first session that could trade the filing).

How to read this document

Where a broker report showsThis document showsWhy
A rating (BUY / ADD / REDUCE / SELL)A state: the latest filed quarter and the measured reactionsan event is a fact; a rating is an opinion that requires SEBI RA registration
A target price and upsideThe current price and the multiples against the groupa target is a forecast; a multiple is a measurement
Estimate years marked EMore audited years; no estimatesMarketPing publishes no forecasts — your own model lives on the Models page

Sources, method and disclosures

This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.

Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in